SLDB
Companies
NASDAQ
Solid Biosciences Inc.
Health Care
$4.65
+$0.65 (+16.25%)
Price Chart
Overview
About SLDB
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Market Cap
$309.3M
Volume
5.9M
Avg. Volume
5.6M
P/E Ratio
-0.9709091
Dividend Yield
0.00%
Employees
111.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.55
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SLDB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$309.3M
Volume5.9M
P/E Ratio-0.97
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025